NM_006950.3:c.1198G>A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_006950.3(SYN1):​c.1198G>A​(p.Asp400Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000411 in 1,095,139 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D400E) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 24)
Exomes 𝑓: 0.000041 ( 0 hom. 19 hem. )

Consequence

SYN1
NM_006950.3 missense

Scores

1
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.72

Publications

0 publications found
Variant links:
Genes affected
SYN1 (HGNC:11494): (synapsin I) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
SYN1 Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, X-linked 1, with variable learning disabilities and behavior disorders
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3529849).
BP6
Variant X-47575235-C-T is Benign according to our data. Variant chrX-47575235-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 465087.
BS2
High Hemizygotes in GnomAdExome4 at 19 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYN1NM_006950.3 linkc.1198G>A p.Asp400Asn missense_variant Exon 10 of 13 ENST00000295987.13 NP_008881.2
SYN1NM_133499.2 linkc.1198G>A p.Asp400Asn missense_variant Exon 10 of 13 NP_598006.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYN1ENST00000295987.13 linkc.1198G>A p.Asp400Asn missense_variant Exon 10 of 13 2 NM_006950.3 ENSP00000295987.7
SYN1ENST00000340666.5 linkc.1198G>A p.Asp400Asn missense_variant Exon 10 of 13 1 ENSP00000343206.4
ENSG00000283743ENST00000638776.2 linkn.3654G>A non_coding_transcript_exon_variant Exon 16 of 16 5

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD2 exomes
AF:
0.00000578
AC:
1
AN:
172896
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000130
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000411
AC:
45
AN:
1095139
Hom.:
0
Cov.:
32
AF XY:
0.0000526
AC XY:
19
AN XY:
360877
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26370
American (AMR)
AF:
0.00
AC:
0
AN:
34873
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19329
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30127
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53344
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40302
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
0.0000535
AC:
45
AN:
840669
Other (OTH)
AF:
0.00
AC:
0
AN:
45995
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
24
ExAC
AF:
0.00000825
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Uncertain:1
Aug 26, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid with asparagine at codon 400 of the SYN1 protein (p.Asp400Asn). The aspartic acid residue is moderately conserved and there is a small physicochemical difference between aspartic acid and asparagine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with SYN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 465087). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Jun 14, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.77
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D;.
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.35
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L
PhyloP100
4.7
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.098
Sift
Uncertain
0.0070
D;D
Sift4G
Benign
0.15
T;T
Polyphen
0.85
P;B
Vest4
0.35
MutPred
0.34
Gain of methylation at K403 (P = 0.0559);Gain of methylation at K403 (P = 0.0559);
MVP
0.28
MPC
0.69
ClinPred
0.33
T
GERP RS
5.2
PromoterAI
-0.013
Neutral
Varity_R
0.32
gMVP
0.90
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772668988; hg19: chrX-47434634; API